ABVC BioPharma
ABVC
ABVC
13 hedge funds and large institutions have $792K invested in ABVC BioPharma in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
57% less capital invested
Capital invested by funds: $1.82M → $792K (-$1.03M)
Holders
13
Holding in Top 10
–
Calls
$10K
Puts
–
Top Buyers
| 1 | +$34.8K | |
| 2 | +$31.1K | |
| 3 | +$20.2K | |
| 4 |
Squarepoint
New York
|
+$17.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.69K |
Top Sellers
| 1 | -$118K | |
| 2 | -$31.7K | |
| 3 | -$24K | |
| 4 |
Jane Street
New York
|
-$18K |
| 5 |
Morgan Stanley
New York
|
-$11K |
